Press Release
Ben Delhey joins as Supervisory Board Member of BOYDSense, the MedTech subsidiary of Alpha MOS
--BOYDSense SAS, a subsidiary of Alpha MOS (EuroNext: ALM), developed a miniaturized respiratory analysis platform to monitor chronic diseases, with a first application in diabetes monitoring. Today, BOYDSense is announcing the arrival mid-June of Ben Delhey as Supervisory Board independent member. Ben Delhey has more than 15 years of senior management experience in the Healthcare […]
Press Release
The University Hospital (CHU) of Toulouse will perform a clinical study for BOYDSense to enhance and validate its algorithm
--The University Hospital (CHU) of Toulouse and BOYDSense entered into an agreement to perform a clinical study to enhance and validate on a cohort of 100 people with type 2 diabetes the accuracy of the non-invasive glucose monitoring device developed by Alpha MOS’ subsidiary BOYDSense.This is the second clinical study ordered by BOYDSense. The first […]
Press Release
Sweet Ventures invests in BOYDSense to bring non-invasive glucose monitoring using breath analysis to people with diabetes
--Toulouse (France) and Vienna (Austria), October 2nd, 2020. Sweet Ventures entered into an investment agreement to support the development of Alpha MOS’ subsidiary BOYDSense into a leading provider of non-invasive breath analysis-based solutions to monitor diabetes and other chronic conditions. Sweet Ventures is an investment group formed by the founders and early team members of […]
Press Release
BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge
--Company’s non-invasive breath analysis technology recognized for its innovation and potential to disrupt glucose monitoring industry. San Bruno, Calif. –  October 29, 2019 – Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades from both investors and […]